López Carvajal, L., Vélez Bernal, I. D., Asela Pinzón, C. X., Cruz, C., Alves, F., Robledo, S., & Arana, B. (2018). A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.
Chicago Style CitationLópez Carvajal, Liliana, Iván Darío Vélez Bernal, Claudia Ximena Asela Pinzón, Claudia Cruz, Fabiana Alves, Sara Robledo, and Byron Arana. A Phase II Study to Evaluate the Safety and Efficacy of Topical 3% Amphotericin B Cream (Anfoleish) for the Treatment of Uncomplicated Cutaneous Leishmaniasis in Colombia. 2018.
MLA CitationLópez Carvajal, Liliana, et al. A Phase II Study to Evaluate the Safety and Efficacy of Topical 3% Amphotericin B Cream (Anfoleish) for the Treatment of Uncomplicated Cutaneous Leishmaniasis in Colombia. 2018.